Chen Changyi, Conklin Brian S, Ren Zeguang, Zhong Dian-sheng
Department of Surgery, Veterans Affairs Medical Center, Decatur, Georgia 30033, USA.
J Surg Res. 2002 Jan;102(1):22-30. doi: 10.1006/jsre.2001.6304.
Although hyperhomocysteinemia has long been recognized as an independent risk factor for vascular disease, the mechanisms of the pathogenesis of homocysteine are largely unknown. The objective of this study was to examine the effect of homocysteine on vasomotor function and endothelial integrity in intact porcine arteries.
Pig coronary artery rings were incubated with homocysteine (10, 50, or 100 microM) for 24 h. Myograph analysis was performed with thromboxane A2 analogue U46619 for contraction and bradykinin or sodium nitroprusside for relaxation. Pig carotid arteries were perfusion-cultured in control and 50 and 100 microM homocysteine treatment groups. The diameter change was analyzed in response to norepinephrine and acetylcholine, respectively. Endothelial morphology and nitric oxide synthase (eNOS) levels were determined by histology analysis.
Endothelial-dependent vasorelaxation (bradykinin) was significantly reduced by 52, 87, and 97% in the pig coronary artery rings treated with 10, 50, and 100 microM homocysteine, respectively, compared to controls (P < 0.05). There were no differences in endothelium-independent vasorelaxation (sodium nitroprusside) or in smooth muscle contractility (U46619) between control and homocysteine-treated groups (P > 0.05). Acetylcholine-induced vasorelaxation was also significantly reduced by 44 and 98% in the pig carotid arteries treated with 50 and 100 microM homocysteine, respectively, compared to controls (P < 0.05). Variable degrees of endothelial cell injury, such as morphology change and detachment, were observed, and eNOS immunoreactivity was markedly reduced in both pig coronary and carotid arteries that were treated with high doses of homocysteine.
These data demonstrated that homocysteine significantly decreased endothelium-dependent vasorelaxation and eNOS immunoreactivity as well as induced marked endothelial injury in both porcine coronary and carotid arteries. This study suggests that homocysteine-mediated endothelial dysfunction and injury may play important roles in vascular lesion formation in the hyperhomocysteinemic patient.
尽管高同型半胱氨酸血症长期以来一直被认为是血管疾病的独立危险因素,但同型半胱氨酸的发病机制在很大程度上尚不清楚。本研究的目的是检测同型半胱氨酸对完整猪动脉血管舒缩功能和内皮完整性的影响。
将猪冠状动脉环与同型半胱氨酸(10、50或100微摩尔)孵育24小时。使用血栓素A2类似物U46619进行收缩实验,使用缓激肽或硝普钠进行舒张实验,进行肌张力分析。将猪颈动脉在对照以及50和100微摩尔同型半胱氨酸处理组中进行灌注培养。分别分析对去甲肾上腺素和乙酰胆碱的直径变化。通过组织学分析确定内皮形态和一氧化氮合酶(eNOS)水平。
与对照组相比,用10、50和100微摩尔同型半胱氨酸处理的猪冠状动脉环中,内皮依赖性血管舒张(缓激肽)分别显著降低了52%、87%和97%(P < 0.05)。对照组和同型半胱氨酸处理组之间,非内皮依赖性血管舒张(硝普钠)或平滑肌收缩性(U46619)没有差异(P > 0.05)。与对照组相比,用50和100微摩尔同型半胱氨酸处理的猪颈动脉中,乙酰胆碱诱导的血管舒张也分别显著降低了44%和98%(P < 0.05)。观察到不同程度的内皮细胞损伤,如形态改变和脱落,并且在高剂量同型半胱氨酸处理的猪冠状动脉和颈动脉中,eNOS免疫反应性明显降低。
这些数据表明,同型半胱氨酸显著降低了内皮依赖性血管舒张和eNOS免疫反应性,并在猪冠状动脉和颈动脉中诱导了明显的内皮损伤。本研究表明,同型半胱氨酸介导的内皮功能障碍和损伤可能在高同型半胱氨酸血症患者的血管病变形成中起重要作用。